You have no items in your shopping cart.
Cart summary
Erlotinib Hydrochloride
Catalog Number: orb1713761
| Catalog Number | orb1713761 |
|---|---|
| Category | Small Molecules |
| Description | EGFR Kinase inhibitor |
| CAS Number | 183319-69-9 |
| Form/Appearance | Solid powder |
| Purity | ≥99% |
| MW | 429.9 |
| Formula | C22H24ClN3O4 |
| Hazard Information | Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
| Solubility (25°C) | Soluble in DMSO at 18 mg/ml with warming; very poorly soluble in ethanol; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility |
| Source | Synthetic |
| Storage | -20°C |
| Alternative names | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinaz Read more... |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Erlotinib hydrochloride [orb154613]
[183319-69-9]
429.8967
C22H24CLN3O4
10 mM * 1 mL in DMSO, 1 g, 10 g, 5 gErlotinib hydrochloride [orb1310677]
99.52%
183319-69-9
429.9
C22H24ClN3O4
100 mg, 500 mg, 1 mL*10mM (in DMSO), 1 g, 50 mgDesmethyl Erlotinib hydrochloride [orb1300610]
99.03%
183320-51-6
415.87
C21H22ClN3O4
50 mg, 25 mg, 10 mg, 5 mg, 2 mg, 100 mg, 1 mg, 1 mL*10mM (in DMSO)
Submit a review
Filter by Rating
- 5 stars
- 4 stars
- 3 stars
- 2 stars
- 1 stars
